Annual D&A
$10.49 M
+$1.26 M+13.65%
December 31, 2024
Summary
- As of March 14, 2025, CTKB annual depreciation & amortization is $10.49 million, with the most recent change of +$1.26 million (+13.65%) on December 31, 2024.
- During the last 3 years, CTKB annual D&A has risen by +$9.25 million (+744.61%).
- CTKB annual D&A is now at all-time high.
Performance
CTKB Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$2.74 M
-$68.00 K-2.42%
December 31, 2024
Summary
- As of March 14, 2025, CTKB quarterly depreciation & amortization is $2.74 million, with the most recent change of -$68.00 thousand (-2.42%) on December 31, 2024.
- Over the past year, CTKB quarterly D&A has increased by +$316.00 thousand (+13.03%).
- CTKB quarterly D&A is now -2.42% below its all-time high of $2.81 million, reached on September 30, 2024.
Performance
CTKB Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$10.49 M
+$316.00 K+3.11%
December 31, 2024
Summary
- As of March 14, 2025, CTKB TTM depreciation & amortization is $10.49 million, with the most recent change of +$316.00 thousand (+3.11%) on December 31, 2024.
- Over the past year, CTKB TTM D&A has increased by +$1.26 million (+13.65%).
- CTKB TTM D&A is now at all-time high.
Performance
CTKB TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
CTKB Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.7% | +13.0% | +13.7% |
| 3 y3 years | +744.6% | +12.1% | +52.5% |
| 5 y5 years | +3294.8% | +12.1% | +52.5% |
CTKB Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +744.6% | -2.4% | +300.1% | at high | +744.6% |
| 5 y | 5-year | at high | +3294.8% | -2.4% | +2510.5% | at high | +9890.5% |
| alltime | all time | at high | +3294.8% | -2.4% | +2510.5% | at high | +9890.5% |
Cytek Biosciences Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $10.49 M(+13.7%) | $2.74 M(-2.4%) | $10.49 M(+3.1%) |
| Sep 2024 | - | $2.81 M(+13.3%) | $10.17 M(+2.5%) |
| Jun 2024 | - | $2.48 M(+0.8%) | $9.92 M(+0.4%) |
| Mar 2024 | - | $2.46 M(+1.4%) | $9.89 M(+7.1%) |
| Dec 2023 | $9.23 M(+63.1%) | $2.42 M(-5.2%) | $9.23 M(+6.5%) |
| Sep 2023 | - | $2.56 M(+4.7%) | $8.67 M(+26.0%) |
| Jun 2023 | - | $2.44 M(+35.8%) | $6.88 M(+14.9%) |
| Mar 2023 | - | $1.80 M(-3.4%) | $5.99 M(+5.8%) |
| Dec 2022 | $5.66 M | $1.86 M(+141.8%) | $5.66 M(+26.3%) |
| Sep 2022 | - | $771.00 K(-50.4%) | $4.48 M(+14.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $1.55 M(+5.7%) | $3.90 M(+53.2%) |
| Mar 2022 | - | $1.47 M(+114.6%) | $2.54 M(+104.9%) |
| Dec 2021 | $1.24 M(+106.0%) | $685.00 K(+262.4%) | $1.24 M(+73.7%) |
| Sep 2021 | - | $189.00 K(-6.0%) | $715.00 K(+1.4%) |
| Jun 2021 | - | $201.00 K(+20.4%) | $705.00 K(+6.0%) |
| Mar 2021 | - | $167.00 K(+5.7%) | $665.00 K(+10.3%) |
| Dec 2020 | $603.00 K(+95.1%) | $158.00 K(-11.7%) | $603.00 K(+35.5%) |
| Sep 2020 | - | $179.00 K(+11.2%) | $445.00 K(+67.3%) |
| Jun 2020 | - | $161.00 K(+53.3%) | $266.00 K(+153.3%) |
| Mar 2020 | - | $105.00 K | $105.00 K |
| Dec 2019 | $309.00 K | - | - |
FAQ
- What is Cytek Biosciences annual depreciation & amortization?
- What is the all time high annual D&A for Cytek Biosciences?
- What is Cytek Biosciences annual D&A year-on-year change?
- What is Cytek Biosciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Cytek Biosciences?
- What is Cytek Biosciences quarterly D&A year-on-year change?
- What is Cytek Biosciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Cytek Biosciences?
- What is Cytek Biosciences TTM D&A year-on-year change?
What is Cytek Biosciences annual depreciation & amortization?
The current annual D&A of CTKB is $10.49 M
What is the all time high annual D&A for Cytek Biosciences?
Cytek Biosciences all-time high annual depreciation & amortization is $10.49 M
What is Cytek Biosciences annual D&A year-on-year change?
Over the past year, CTKB annual depreciation & amortization has changed by +$1.26 M (+13.65%)
What is Cytek Biosciences quarterly depreciation & amortization?
The current quarterly D&A of CTKB is $2.74 M
What is the all time high quarterly D&A for Cytek Biosciences?
Cytek Biosciences all-time high quarterly depreciation & amortization is $2.81 M
What is Cytek Biosciences quarterly D&A year-on-year change?
Over the past year, CTKB quarterly depreciation & amortization has changed by +$316.00 K (+13.03%)
What is Cytek Biosciences TTM depreciation & amortization?
The current TTM D&A of CTKB is $10.49 M
What is the all time high TTM D&A for Cytek Biosciences?
Cytek Biosciences all-time high TTM depreciation & amortization is $10.49 M
What is Cytek Biosciences TTM D&A year-on-year change?
Over the past year, CTKB TTM depreciation & amortization has changed by +$1.26 M (+13.65%)